Champions Oncology (CSBR) Operating Expenses (2010 - 2026)

Champions Oncology has reported Operating Expenses for 17 years, with the latest figure at $14.4 million in Q2 2026.

• On a quarterly basis, Operating Expenses changed 0.03% year-over-year to $14.4 million in Q2 2026; TTM through Apr 2026 was $60.6 million, a 15.6% increase from a year earlier, with the FY2026 full-year figure at $60.6 million, up 15.6% from the prior year.
• Operating Expenses was $14.4 million for Q2 2026 at Champions Oncology, down from $16.8 million in the prior quarter.
• The five-year high for Operating Expenses was $16.8 million in Q1 2026, with the low at $12.4 million in Q1 2022.
• Average Operating Expenses over 5 years is $14.2 million, with a median of $14.3 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2026: Operating Expenses dropped 15.75% in 2024, then surged 34.25% in 2026.
• Over 5 years, Operating Expenses stood at $14.3 million in 2022, then declined by 5.23% to $13.5 million in 2023, then slipped by 5.7% to $12.8 million in 2024, then gained by 16.41% to $14.8 million in 2025, then dropped by 3.32% to $14.4 million in 2026.
• The last three Operating Expenses figures came in at $14.4 million (Q2 2026), $16.8 million (Q1 2026), and $14.8 million (Q4 2025), per Business Quant data.